Exosens (LON:0EXO)

Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of GBP 1.92 billion. The enterprise value is 2.07 billion.

Market Cap	1.92B
Enterprise Value	2.07B

Important Dates

The next estimated earnings date is Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	May 28, 2025

Share Statistics

Current Share Class	50.76M
Shares Outstanding	n/a
Shares Change (YoY)	+56.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.78M

Valuation Ratios

The trailing PE ratio is 40.18 and the forward PE ratio is 27.55.

PE Ratio	40.18
Forward PE	27.55
PS Ratio	5.19
PB Ratio	5.21
P/TBV Ratio	32.09
P/FCF Ratio	39.22
P/OCF Ratio	22.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.88, with an EV/FCF ratio of 42.40.

EV / Earnings	43.44
EV / Sales	5.52
EV / EBITDA	21.88
EV / EBIT	26.13
EV / FCF	42.40

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.63.

Current Ratio	2.51
Quick Ratio	1.61
Debt / Equity	0.63
Debt / EBITDA	2.46
Debt / FCF	4.70
Interest Coverage	6.10

Financial Efficiency

Return on equity (ROE) is 13.73% and return on invested capital (ROIC) is 8.51%.

Return on Equity (ROE)	13.73%
Return on Assets (ROA)	6.91%
Return on Invested Capital (ROIC)	8.51%
Return on Capital Employed (ROCE)	12.29%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	1,401
Asset Turnover	0.52
Inventory Turnover	1.72

Taxes

In the past 12 months, Exosens has paid 16.70 million in taxes.

Income Tax	16.70M
Effective Tax Rate	25.91%

Stock Price Statistics

The stock price has increased by +111.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+111.65%
50-Day Moving Average	35.57
200-Day Moving Average	n/a
Relative Strength Index (RSI)	64.32
Average Volume (20 Days)	94,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of GBP 370.05 million and earned 47.77 million in profits. Earnings per share was 0.94.

Revenue	370.05M
Gross Profit	221.74M
Operating Income	78.23M
Pretax Income	64.47M
Net Income	47.77M
EBITDA	89.63M
EBIT	78.23M
Earnings Per Share (EPS)	0.94

Balance Sheet

The company has 76.96 million in cash and 230.11 million in debt, giving a net cash position of -153.14 million.

Cash & Cash Equivalents	76.96M
Total Debt	230.11M
Net Cash	-153.14M
Net Cash Per Share	n/a
Equity (Book Value)	368.17M
Book Value Per Share	7.25
Working Capital	162.00M

Cash Flow

In the last 12 months, operating cash flow was 86.67 million and capital expenditures -37.73 million, giving a free cash flow of 48.94 million.

Operating Cash Flow	86.67M
Capital Expenditures	-37.73M
Free Cash Flow	48.94M
FCF Per Share	n/a

Margins

Gross margin is 59.92%, with operating and profit margins of 21.14% and 12.91%.

Gross Margin	59.92%
Operating Margin	21.14%
Pretax Margin	17.42%
Profit Margin	12.91%
EBITDA Margin	24.22%
EBIT Margin	21.14%
FCF Margin	13.23%

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 0.19%.

Dividend Per Share	0.08
Dividend Yield	0.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	9.11%
Buyback Yield	-56.36%
Shareholder Yield	-56.18%
Earnings Yield	2.49%
FCF Yield	2.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 3.03 and a Piotroski F-Score of 6.

Altman Z-Score	3.03
Piotroski F-Score	6